Published in Mol Biochem Parasitol on March 01, 1991
Lipoic acid metabolism in microbial pathogens. Microbiol Mol Biol Rev (2010) 1.18
Identification of a novel prostaglandin f(2alpha) synthase in Trypanosoma brucei. J Exp Med (2000) 1.17
Kinetoplastid glucose transporters. Biochem J (1997) 1.13
Three mitochondrial DNA polymerases are essential for kinetoplast DNA replication and survival of bloodstream form Trypanosoma brucei. Eukaryot Cell (2011) 0.86
Probing the metabolic network in bloodstream-form Trypanosoma brucei using untargeted metabolomics with stable isotope labelled glucose. PLoS Pathog (2015) 0.83
Adaptations in the glucose metabolism of procyclic Trypanosoma brucei isolates from tsetse flies and during differentiation of bloodstream forms. Eukaryot Cell (2009) 0.81
Dual functions of α-ketoglutarate dehydrogenase E2 in the Krebs cycle and mitochondrial DNA inheritance in Trypanosoma brucei. Eukaryot Cell (2012) 0.80
ATP-driven and AMPK-independent autophagy in an early branching eukaryotic parasite. Autophagy (2017) 0.76
Cultivation and in vitro cloning or procyclic culture forms of Trypanosoma brucei in a semi-defined medium. Short communication. Acta Trop (1979) 8.43
Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell (1999) 4.89
The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro. Acta Trop (1997) 4.73
Human African trypanosomiasis: pharmacological re-engagement with a neglected disease. Br J Pharmacol (2007) 2.96
Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res (2000) 2.83
Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial. Lancet (2000) 2.60
Synchronous change of atmospheric CO2 and Antarctic temperature during the last deglacial warming. Science (2013) 2.42
A simple monophasic medium for axenic culture of hemoflagellates. J Parasitol (1976) 2.32
Microscopical Investigation of the Nervous System in Three Cases of Spontaneous Myxoedema. Proc R Soc Med (1913) 1.91
Critical roles of glycosylphosphatidylinositol for Trypanosoma brucei. Proc Natl Acad Sci U S A (2000) 1.69
Efficacy of the diamidine DB75 and its prodrug DB289, against murine models of human African trypanosomiasis. Acta Trop (2008) 1.64
Survival of Trypanosoma brucei in the tsetse fly is enhanced by the expression of specific forms of procyclin. J Cell Biol (1997) 1.63
A major surface glycoprotein of trypanosoma brucei is expressed transiently during development and can be regulated post-transcriptionally by glycerol or hypoxia. Genes Dev (2000) 1.63
Stimulating effect of citrate and cis-Aconitate on the transformation of Trypanosoma brucei bloodstream forms to procyclic forms in vitro. Z Parasitenkd (1981) 1.51
The surface coat of procyclic Trypanosoma brucei: programmed expression and proteolytic cleavage of procyclin in the tsetse fly. Proc Natl Acad Sci U S A (2001) 1.41
In vitro cultivation of bloodstream forms of Trypanosoma brucei, T. rhodesiense, and T. gambiense. J Protozool (1981) 1.32
PPAR gamma and the control of adipogenesis. Biochimie (1997) 1.24
In vivo trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors. Antimicrob Agents Chemother (1996) 1.24
The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part I. Curr Med Chem (2012) 1.20
Trypanosoma brucei CTP synthetase: a target for the treatment of African sleeping sickness. Proc Natl Acad Sci U S A (2001) 1.19
Leishmanicidal activity of new megazol derivatives. Med Chem (2009) 1.19
In vitro assays to determine drug sensitivities of African trypanosomes: a review. Acta Trop (1993) 1.17
Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D,L-alpha-difluoromethylornithine. Antimicrob Agents Chemother (1997) 1.17
Antitrypanosomal and antiplasmodial activity of medicinal plants from Côte d'Ivoire. J Ethnopharmacol (2004) 1.15
Effects of elevated CO2 on grain yield and quality of wheat: results from a 3-year free-air CO2 enrichment experiment. Plant Biol (Stuttg) (2009) 1.15
Stage-specific expression and targeting of cyst wall protein-green fluorescent protein chimeras in Giardia. Mol Biol Cell (2000) 1.13
Disulphide bonds in wheat gluten: cystine peptides derived from gluten proteins following peptic and thermolytic digestion. Z Lebensm Unters Forsch (1995) 1.13
In vitro and in vivo activities of trybizine hydrochloride against various pathogenic trypanosome species. Antimicrob Agents Chemother (1998) 1.12
Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12
Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11
Evaluation of African medicinal plants for their in vitro trypanocidal activity. J Ethnopharmacol (1996) 1.10
Antiplasmodial, anti-trypanosomal, anti-leishmanial and cytotoxicity activity of selected Tanzanian medicinal plants. Tanzan J Health Res (2009) 1.09
The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part II. Curr Med Chem (2012) 1.09
Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-alpha-difluoromethylornithine (DFMO). Trop Med Parasitol (1995) 1.08
Pharmacokinetic properties of the trypanocidal drug melarsoprol. Chemotherapy (1993) 1.08
Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett (2013) 1.08
Immunopeptides in the defense reactions of Glossina morsitans to bacterial and Trypanosoma brucei brucei infections. Insect Biochem Mol Biol (2002) 1.07
Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(NN)) = 2.76 TeV. Phys Rev Lett (2011) 1.05
Fasciola hepatica: action in vitro of triclabendazole on immature and adult stages. Exp Parasitol (1987) 1.05
Induction and repair of formaldehyde-induced DNA-protein crosslinks in repair-deficient human cell lines. Mutagenesis (2000) 1.04
Minor cytotoxic and antibacterial compounds from the rhizomes of Amomum aculeatum. Phytochemistry (2001) 1.03
Efficacy of the novel diamidine compound 2,5-Bis(4-amidinophenyl)- furan-bis-O-Methlylamidoxime (Pafuramidine, DB289) against Trypanosoma brucei rhodesiense infection in vervet monkeys after oral administration. Antimicrob Agents Chemother (2008) 1.01
Physical properties of autoclaved bone. Torsion test of rabbit diaphyseal bone. Acta Orthop Scand (1986) 1.01
Synthesis and biological evaluation of s-triazine substituted polyamines as potential new anti-trypanosomal drugs. J Med Chem (2001) 1.00
Bioassay-guided isolation of a diastereoisomer of kolavenol from Entada abyssinica active on Trypanosoma brucei rhodesiense. J Ethnopharmacol (1998) 0.98
Production of muons from heavy flavor decays at forward rapidity in pp and Pb-Pb collisions at sqrt[s(NN)]=2.76 TeV. Phys Rev Lett (2012) 0.98
Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment. Ann Oncol (2004) 0.97
Comparison of the in vitro drug sensitivity of Trypanosoma brucei gambiense strains from West and Central Africa isolated in the periods 1960-1995 and 1999-2004. Acta Trop (2006) 0.97
Immune response of Drosophila melanogaster to infection with the flagellate parasite Crithidia spp. Insect Biochem Mol Biol (2001) 0.97
Quantitative ultrastructural investigations of mitochondrial development in Leishmania donovani during transformation. J Protozool (1976) 0.97
Studies on compounds promoting the in vitro transformation of Trypanosoma brucei from bloodstream to procyclic forms. Parasitol Res (1994) 0.96
[Sweat glands on the back of the auricles]. Arch Klin Exp Dermatol (1967) 0.96
Killing of Giardia lamblia by human milk is mediated by unsaturated fatty acids. Antimicrob Agents Chemother (1986) 0.95
The variant-specific surface protein of Giardia, VSP4A1, is a glycosylated and palmitoylated protein. Biochem J (1997) 0.94
A review of bovine urothelial tumours and tumour-like lesions of the urinary bladder. J Comp Pathol (2009) 0.94
Trypanosoma brucei: morphometric changes and loss of infectivity during transformation of bloodstream forms to procyclic culture forms in vitro. Exp Parasitol (1979) 0.93
Centrality dependence of the charged-particle multiplicity density at midrapidity in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2011) 0.93
Infection of organotypic slice cultures from rat central nervous tissue with Trypanosoma brucei brucei. Int J Med Microbiol (2000) 0.93
Electrophoretic characterization of Giardia isolated from humans, cattle, sheep, and a dog in Switzerland. J Parasitol (1990) 0.93
Glycosylation and palmitoylation are common modifications of giardia variant surface proteins. Mol Biochem Parasitol (2000) 0.92
Comparative antiplasmodial, leishmanicidal and antitrypanosomal activities of several biflavonoids. Phytomedicine (2005) 0.92
Cultivation of vertebrate infective forms derived from metacyclic forms of pleomorphic Trypanosoma brucei stocks. Short communication. Acta Trop (1979) 0.91
Clinical and serologic responses to human 'apathogenic' trypanosomes. Trans R Soc Trop Med Hyg (2005) 0.91
Parasitological detection of Trypanosoma brucei gambiense in serologically negative sleeping-sickness suspects from north-western Uganda. Ann Trop Med Parasitol (1998) 0.91
A new semi-defined medium for Trypanosoma brucei sspp. Acta Trop (1977) 0.91
Inhibition of Leishmania donovani transformation by hamster spleen homogenates and active human lymphocytes. Nature (1976) 0.90
Kinetoplast DNA and molecular karyotypes of Trypanosoma evansi and Trypanosoma equiperdum from China. Mol Biochem Parasitol (1992) 0.90
Mechanisms of respiration and phosphorylation in Ascaris muscle mitochondria. Mol Biochem Parasitol (1980) 0.90
Incorporation of nonviable bone grafts. Autoclaved autogeneic and frozen allogeneic bone grafts compared in the rabbit. Acta Orthop Scand (1987) 0.89
Pyrazolopyrimidine metabolism in African trypanosomes: metabolic similarities to Trypanosoma cruzi and Leishmania spp. Mol Biochem Parasitol (1980) 0.89
Turkish freshwater and marine macrophyte extracts show in vitro antiprotozoal activity and inhibit FabI, a key enzyme of Plasmodium falciparum fatty acid biosynthesis. Phytomedicine (2006) 0.88
["Pitting" of the fingernails]. Dermatologica (1968) 0.88
Trypanosomiasis of domestic animals in China. Parasitol Today (1993) 0.88
Promastigote infectivity in Leishmania infantum. Parasitol Res (1991) 0.87
Oocyte maturation in vitro: contribution of the oviduct to total maturation in Xenopus laevis. Experientia (1975) 0.87
Midrapidity antiproton-to-proton ratio in pp collisons at sqrt[s]=0.9 and 7 TeV measured by the ALICE experiment. Phys Rev Lett (2010) 0.87
Cytotoxicity of Echinococcus granulosus cyst fluid in vitro. Z Parasitenkd (1981) 0.87
Distribution of developmentally regulated trans-sialidases in the Kinetoplastida and characterization of a shed trans-sialidase activity from procyclic Trypanosoma congolense. Acta Trop (1995) 0.86
African buffalo serum contains novel trypanocidal protein. J Eukaryot Microbiol (1994) 0.86
An approach to use an unusual adenosine transporter to selectively deliver polyamine analogues to trypanosomes. Bioorg Med Chem Lett (1998) 0.86
Epidemiology of contact dermatitis in Geneva (1000 cases). Contact Dermatitis (1975) 0.86
Microscopic and flow cytophotometric analysis of parasitemia in cultures of Plasmodium falciparum vitally stained with Hoechst 33342--application to studies of antimalarial agents. Z Parasitenkd (1986) 0.86
Evidence for an exotic S= -2, Q= -2 baryon resonance in proton-proton collisions at the CERN SPS. Phys Rev Lett (2004) 0.86
Establishment of a panel of reference Trypanosoma evansi and Trypanosoma equiperdum strains for drug screening. Vet Parasitol (2007) 0.86
Production of metacyclic forms by cyclical transmission of west African Trypanosoma (T.) brucei isolates from man and animals. Acta Trop (1988) 0.86
Pacemaker dermatitis. Contact Dermatitis (1980) 0.85
In vitro antitrypanosomal activity of African plants used in traditional medicine in Uganda to treat sleeping sickness. Trop Med Int Health (1996) 0.85
Comparison of genetic groups determined by molecular and immunological analyses of Giardia isolated from animals and humans in Switzerland and Australia. Parasitol Res (1996) 0.84
[Syphillis in Geneva during the past two years: epidemiology, serology and treatment]. Schweiz Rundsch Med Prax (1971) 0.84
Variant cysteine-rich surface proteins of Giardia isolates from human and animal sources. Infect Immun (1993) 0.84
(S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine [(S)-HPMPA]: a purine analogue with trypanocidal activity in vitro and in vivo. Trop Med Int Health (1996) 0.84
cAMP-specific phosphodiesterase TbPDE1 is not essential in Trypanosoma brucei in culture or during midgut infection of tsetse flies. Mol Biochem Parasitol (2001) 0.84
A novel in vitro screening assay for trypanocidal activity using the fluorescent dye BCECF-AM. Trop Med Parasitol (1995) 0.84
Pharmacokinetics of melarsoprol in uninfected vervet monkeys. Acta Trop (1994) 0.83
The complete amino acid sequence of a trypsin inhibitor from Bauhinia variegata var. candida seeds. J Protein Chem (1998) 0.83
The isoenzyme characteristics of Trypanosoma evansi and Trypanosoma equiperdum isolated from domestic stocks in China. Ann Trop Med Parasitol (1992) 0.83
Primary structure and biochemical properties of a variant-specific surface protein of Giardia. Mol Biochem Parasitol (1997) 0.83
Separation of a cysteine-rich surface antigen-expressing variant from a cloned Giardia isolate by fluorescence-activated cell sorting. Parasitol Res (1994) 0.83
[Basophils in lupus erythematosus and other dermatoses]. Dermatologica (1972) 0.83